Target assessment is challenging due to limited access to high-quality, disease-relevant data. With DISQOVER, this pharma company is accelerating data curation and report generation.

This global pharmaceutical company is utilizing DISQOVER to harmonize legacy data, empowering cohort selection in just a few clicks.

Discover how ONTOFORCE's DISQOVER integrates GXP and public data, boosting innovation in pharma through enhanced data strategy.

Explore how ONTOFORCE’s DISQOVER platform revolutionizes data consolidation in the pharmaceutical industry, enhancing research efficiency.

The Princess Máxima Center leverages DISQOVER in a mission to cure all children with cancer, optimizing data use in healthcare and research.

Explore PRISMA Consortium's role in Alzheimer's research with ONTOFORCE's DISQOVER. Uniting healthcare and tech, it aims for breakthroughs in personalized medicine. 

Our customer is a leading, global pharmaceutical company that is committed to delivering innovative medicines to improve patient outcomes. They are heavily focused on oncology.

Our customer is a multinational science and technology company that provides patients with innovative medicines and technologies within multiple therapeutic areas.

Our customer is an American pharmaceutical company focused on developing treatments and technologies for rare diseases and conditions.